Ali El‐Gayed - Concepedia

Author

Ali El‐Gayed

Also Known As

A El-Gayed, A. El-Gayed, A. Elgayed, A.A.H. El-Gayed, Ali A.H. El-Gayed, Ali Abdel Halim El-Gayed, Ali El-Gayed, Ali El‐Gayed

Publications

570

Citations

H-Index

Concepts

All Affiliations

University of Saskatchewan Saskatchewan Cancer Agency University of Calgary University of California, San Francisco Emory University

About

Ali El‐Gayed is an author at University of Saskatchewan specializing in medicine, radiology, and medical imaging.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	367
2	Health Sciences	4	4	203
3	Engineering	1	1	44
4	Allergy	1	1	39
5	Cell Biology	1	1	27

Ali El‐Gayed

Publications

544

Citations

H-Index

Page 1

	Year	Citations
Time trend of patient setup deviations during pelvic irradiation using electronic portal imaging Ali El‐Gayed, Arjan Bel, R.E. Vijlbrief, Radiotherapy and Oncology Electronic Portal ImagingMedical ImagingTreatment VerificationMedicineInterventional Radiology	1993	120
Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers David Skarsgard, Pat Cadman, Ali El‐Gayed, Radiation Oncology	2010	62
Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy Brian C. Baumann, Walter Bosch, Amit Bahl, International Journal of Radiation OncologyBiologyPhysics Radical CystectomyUrologySurgical OncologyRadiation TherapyGenitourinary Cancer	2016	54
An algorithm for automatic analysis of portal images: clinical evaluation for prostate treatments Kenneth G. A. Gilhuijs, Ali El‐Gayed, Marcel van Herk, Radiotherapy and Oncology Geometric ModelingPortal ImagesUrologyImage AnalysisEngineering	1993	44
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial Daniel Krauss, Theodore Karrison, Alvaro A. Martinez, Journal of Clinical Oncology	2023	41
HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination Tim Hon Man Chan, Amer Sami, Ali El‐Gayed, Gene Therapy VaccinationCross-protectionAllergyVaccine DevelopmentDna Vaccination	2006	39
Dose–volume analysis of locoregional recurrences in head and neck IMRT, as determined by deformable registration: A prospective multi-institutional trial A. Shakam, Rufus Scrimger, Derek Liu, Radiotherapy and Oncology Medical ImagingDeformable RegistrationHead And Neck CancerHead And Neck SurgeryNeck Disorder	2011	34
Combined radiation therapy and dendritic cell vaccine for treating solid tumors with liver micro‐metastasis Zhuang Chen, Dajing Xia, Xuguang Bi, The Journal of Gene Medicine	2004	28
Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice S Sas, Tim Hon Man Chan, Amer Sami, Cancer Gene Therapy VaccinationImmunologyTherapeutic VaccineCtl ResponsesCancer Vaccines	2008	27
Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6) Jolie Ringash, John Waldron, Lillian L. Siu, European Journal of Cancer Radiation TherapyMedicineCancer ManagementPhase IiiNasopharyngeal Cancer	2016	26

Page 1